Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2014
09/12/2014WO2014135955A1 Pyrimidine carboxamides as sodium channel blockers
09/12/2014WO2014135896A2 Methods
09/12/2014WO2014135891A1 Pharmaceutical compositions for rectal administration
09/12/2014WO2014135876A1 Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
09/12/2014WO2014135851A1 Combination treatment
09/12/2014WO2014135834A1 Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator
09/12/2014WO2014135776A1 Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
09/12/2014WO2014135674A1 Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
09/12/2014WO2014135638A1 Piroxicam for use in the prophylactic and therapeutic treatment of cmv infections
09/12/2014WO2014135630A1 Nano-microdelivery systems for oromucosal delivery of an active ingredient
09/12/2014WO2014135617A1 Novel sulfonamide trpa1 receptor antagonists
09/12/2014WO2014135611A1 Combination therapy for neoplasia treatment
09/12/2014WO2014135572A1 Tablet formulation of a pi3kalpha inhibitor
09/12/2014WO2014135561A1 New dihydroquinoline-2-one derivatives as aldosterone synthase (cyp1 1 b2 or cyp1 1 b1 ) inhibitors
09/12/2014WO2014135545A1 Solid dispersion comprising amorphous lorcaserin hydrochloride
09/12/2014WO2014135529A1 Mixture of fatty acids for use in the treatment of inflammatory pathologies
09/12/2014WO2014135524A1 Cabazitaxel and its use for treating metastatic prostate cancers
09/12/2014WO2014135495A1 Antiviral compounds
09/12/2014WO2014135483A1 Antiviral compounds
09/12/2014WO2014135480A1 Substituted thiazolopyrimidines
09/12/2014WO2014135473A1 Inhibitors of bruton's tyrosine kinase
09/12/2014WO2014135472A1 Antiviral compounds
09/12/2014WO2014135471A1 Antiviral compounds
09/12/2014WO2014135460A1 Use of (rs)-s-cyclopropyl-s-(4-{[4-{[(1r,2r)-2-hydroxy-1-methylpropyl]- oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide for treatment of specific tumours
09/12/2014WO2014135439A1 Novel halogen-substituted compounds
09/12/2014WO2014135437A1 Novel halogen-substituted compounds
09/12/2014WO2014135423A1 N-heteroaryl substituted aniline derivatives as hcv-antivirals
09/12/2014WO2014135422A1 Antiviral compounds
09/12/2014WO2014135245A1 9-(aryl or heteroaryl)-2-(pyrazolyl, pyrrolidinyl or cyclopentyl)aminopurine derivatives as anticancer agents
09/12/2014WO2014135244A1 Triazolo[4,5-d]pyrimidine derivatives for the treatment of diseases such as cancer
09/12/2014WO2014135170A1 Novel formula of iron based nanocomposites for rapid and efficient treatment of iron deficiency anemia
09/12/2014WO2014135123A1 17α-ethynyl-androst-5-ene-3β,7β,17β-triol ophthalmic preparation
09/12/2014WO2014135107A1 Novel nucleoside phosphoramidate compound and use thereof
09/12/2014WO2014135043A1 Crystal form of ixabepilone and the preparation method and use thereof
09/12/2014WO2014135028A1 Pyridopyrimidine or pyrimidopyrimidine compound, preparation method, pharmaceutical composition and use thereof
09/12/2014WO2014134968A1 Pyrrolidonopyrazole compounds and use thereof as drugs
09/12/2014WO2014134922A1 Meloxicam eye drops and preparation method and use thereof
09/12/2014WO2014134853A1 Proprietary chinese medicine suitable for global tobacco control, preparation method and use thereof
09/12/2014WO2014134840A1 Treatment of cervical cancer and/or ovarian cancer using transcription factor modulator
09/12/2014WO2014134833A1 Edible composition, preparation method therefor, and food product comprising the composition
09/12/2014WO2014134832A1 Composition and preparation method thereof
09/12/2014WO2014134800A1 Treatment of cervical cancer and/or ovarian cancer using transcription factor modulator
09/12/2014WO2014134774A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/12/2014WO2014134772A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/12/2014WO2014134750A1 2,6,9-trisubstituted purine derivative and preparation method and use thereof
09/12/2014WO2014134731A1 Antimicrobial-antibiofilm compositions and methods of use thereof
09/12/2014WO2014134709A1 Topical use of an antimicrobial formulation
09/12/2014WO2014134705A1 Quinoline sulfonyl derivatives and uses thereof
09/12/2014WO2014134701A1 Antimicrobial-antibiofilm compositions and methods of use thereof
09/12/2014WO2014134689A1 Polymer conjugate for delivery of a bioactive agent
09/12/2014WO2013123290A9 Methods of treating amyotrophic lateral sclerosis
09/12/2014WO2013001544A9 Anti-thrombotic compounds
09/11/2014US20140259191 Fish anesthetic and method
09/11/2014US20140257238 Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device
09/11/2014US20140257170 Method for Improving the Efficacy of Curcuminoids and Their Analogs
09/11/2014US20140256828 Stable liquid formulations of volatile gas anesthetics
09/11/2014US20140256827 Method Improve Spatial Memory Via Pterostilbene Administration
09/11/2014US20140256823 Transmucosal drug delivery system
09/11/2014US20140256822 Transmucosal drug delivery system
09/11/2014US20140256821 Intrannasal administration of ketamine to treat depression
09/11/2014US20140256820 Therapeutic agent for blood-brain barrier disruption syndrome
09/11/2014US20140256818 Nano-suspension process
09/11/2014US20140256816 Adamantyl Derivatives as Therapeutic Agents
09/11/2014US20140256815 Use of nitrated lipids for treatment of side effects of toxic medical therapies
09/11/2014US20140256813 Methods for the treatment of brain injury using omega-3 fatty acids
09/11/2014US20140256809 Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
09/11/2014US20140256808 Use of Ketogenic Compounds for Treatment of Age-Associated Memory Impairment
09/11/2014US20140256807 Methods of treatment using ammonia-scavenging drugs
09/11/2014US20140256806 Prophylactic agent for chronic kidney disease
09/11/2014US20140256805 NEUROACTIVE SUBSTITUTED CYCLOPENTA[b]PHENANTHRENES AS MODULATORS FOR GABA TYPE-A RECEPTORS
09/11/2014US20140256804 Pharmaceutical composition
09/11/2014US20140256798 Talen-based gene correction
09/11/2014US20140256797 Modulation of transthyretin expression
09/11/2014US20140256795 Co-activation of mtor and stat3 pathways to promote neuronal survival and regeneration
09/11/2014US20140256793 MEDICAMENT FOR DISEASES ASSOCIATED WITH AMYLOID beta AND SCREENING THEREOF
09/11/2014US20140256792 Compounds for the treatment of ischemic injury
09/11/2014US20140256789 Composition and methods for modulating cell proliferation and cell death
09/11/2014US20140256786 Compositions and methods for treatment of mitochondrial diseases
09/11/2014US20140256783 Substrate and method for production thereof
09/11/2014US20140256781 Novel Formulation of Indomethacin
09/11/2014US20140256780 Pyrazole derivatives as modulators of hepatocyte growth factor (scatter factor) activity
09/11/2014US20140256779 Novel compounds as opioid receptor modulators
09/11/2014US20140256778 High affinity beta lactamase inhibitors
09/11/2014US20140256772 Pharmaceutical compositions that inhibit disproportionation
09/11/2014US20140256768 Heterocyclic molecules as apoptosis inducers
09/11/2014US20140256766 Transmucosal drug delivery system
09/11/2014US20140256765 Transmucosal drug delivery system
09/11/2014US20140256764 Tamper resistant dosage form comprising an adsorbent and an adverse agent
09/11/2014US20140256763 Pain medicine combination and uses thereof
09/11/2014US20140256762 Artemisinin-based combination therapy for treating viral mediated disease
09/11/2014US20140256761 Enhanced artemisinin-based combination therapy for treating parasitic mediated disease
09/11/2014US20140256760 Reduction or prevention of alcohol reaction with dietary supplements
09/11/2014US20140256758 Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients
09/11/2014US20140256757 Administration of dipeptidyl peptidase inhibitors
09/11/2014US20140256752 Drug Combinations and Uses in Treating a Coughing Condition
09/11/2014US20140256751 Drug Combinations and Uses in Treating a Coughing Condition
09/11/2014US20140256750 Drug Combinations and Uses in Treating a Coughing Condition
09/11/2014US20140256749 Methods and compositions for transdermal delivery of caffeine in the form of solutions or suspensions
09/11/2014US20140256748 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same
09/11/2014US20140256746 Methods for Treating Osteoarthritis
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 7860